Orthocaresp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2010-09-29
Share capital
51,500.00 PLN
Registered address
Bytomska 64, 41-940 Piekary Śląskie, Poland

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 91 days for 2021).

  • 2025not filed
  • 202413/08/2025
  • 202318/07/2024
  • 202231/07/2023
  • 202114/10/2022
  • 202012/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

National Health Fund (NFZ) contracts

Orthocare has been an NFZ healthcare provider since 2012. In 2013 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2013
Supply of medical devices classified as orthopedic devices and assistive productsśląskie1USD 0.00

Authorized Representatives

Agnieszka Teresa Macha – Attorney-in-fact (sole)
Michał Piotr Mielnik – President of the Management Board

Manner of representation

Each member of the management board is entitled to represent the company and make declarations on its behalf independently.

Ownership

OwnerSharesShare valueStake
Jakub Michał Mielnikage 32
33$4,457.0532.0388%
Michał Piotr Mielnikage 59
70$9,454.3567.9612%

Michał Piotr Mielnik and Jakub Michał Mielnik hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2010-11-01 to 2023-11-30.

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Competitors

Name
Anpharm Przedsiębiorstwo FarmaceutyczneS.A.
Celon PharmaS.A.
Silesian Pharmasp. z o.o.
Biofaktorsp. z o.o.
Biomarsp. z o.o.
Natur DayS.A.
Nature's Voicesp. z o.o.
Vilowaysp. z o.o.
AR-NETsp. z o.o.
Amorphis Pharma Developmentsp. z o.o.

Change history

DateEvent
2015-03-19Name change
2013-05-31Share capital increase
2011-01-18Address change
2010-09-29Entered in the register

FAQ

Last updated: 2026-10-13